Literature DB >> 21917494

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype.

Agnieszka Jurecka1, Adam Golda, Violetta Opoka-Winiarska, Ewa Piotrowska, Anna Tylki-Szymańska.   

Abstract

We present here the first literature description of a predominantly cardiac phenotype in a patient homozygous for missense mutation p.R152W in the N-acetylogalactosamine-4-sulfatase (arylsulfatase B, ARSB) gene. An adult Caucasian woman, who displayed very few symptoms up to her late thirties, was diagnosed with mucopolysaccharidosis type VI (MPS VI) after her hospitalization due to acute heart failure originating mainly from valve disease. In addition to her cardiac phenotype some musculoskeletal involvement without other MPS characteristic features were found. Despite the common pharmacologic treatment and implementation of enzyme replacement therapy with galsulfase the patient died at the age of 38 years because of decompensation of chronic heart failure.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917494     DOI: 10.1016/j.ymgme.2011.08.024

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  8 in total

1.  A novel approach in diagnosing multiple dentigerous cysts using CBCT illustration indicative of Mucopolysaccharidosis VI - a case report.

Authors:  Shalu Rai; Deepankar Misra; Akansha Misra; Ankit Jain; Ashish Verma; Dimple Grover; Ayesha Haris
Journal:  J Med Life       Date:  2022-04

2.  Illness perception and clinical treatment experiences in patients with M. Maroteaux-Lamy (mucopolysaccharidosis type VI) and a Turkish migration background in Germany.

Authors:  Hansjörg Dilger; Linn Leissner; Lenka Bosanska; Christina Lampe; Ursula Plöckinger
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

3.  Prevalence rates of mucopolysaccharidoses in Poland.

Authors:  Agnieszka Jurecka; Agnieszka Ługowska; Adam Golda; Barbara Czartoryska; Anna Tylki-Szymańska
Journal:  J Appl Genet       Date:  2014-12-04       Impact factor: 3.240

Review 4.  Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene.

Authors:  Rosella Tomanin; Litsa Karageorgos; Alessandra Zanetti; Moeenaldeen Al-Sayed; Mitch Bailey; Nicole Miller; Hitoshi Sakuraba; John J Hopwood
Journal:  Hum Mutat       Date:  2018-09-17       Impact factor: 4.878

5.  Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase.

Authors:  Marion M Brands; Marianne Hoogeveen-Westerveld; Marian A Kroos; Willemieke Nobel; George J Ruijter; Lale Özkan; Iris Plug; Daniel Grinberg; Lluïsa Vilageliu; Dicky J Halley; Ans T van der Ploeg; Arnold J Reuser
Journal:  Orphanet J Rare Dis       Date:  2013-04-04       Impact factor: 4.123

Review 6.  Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases.

Authors:  Joanna Jakóbkiewicz-Banecka; Magdalena Gabig-Cimińska; Zyta Banecka-Majkutewicz; Bogdan Banecki; Alicja Węgrzyn; Grzegorz Węgrzyn
Journal:  Metab Brain Dis       Date:  2013-12-05       Impact factor: 3.584

Review 7.  Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature.

Authors:  Agnieszka Jurecka; Ekaterina Zakharova; Vera Malinova; Elena Voskoboeva; Anna Tylki-Szymańska
Journal:  Clin Rheumatol       Date:  2013-11-13       Impact factor: 2.980

8.  Human pulmonary artery endothelial cells in the model of mucopolysaccharidosis VI present a prohypertensive phenotype.

Authors:  Adam Golda; Agnieszka Jurecka; Karolina Gajda; Anna Tylki-Szymańska; Anna Lalik
Journal:  Mol Genet Metab Rep       Date:  2015-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.